The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

This is why Ozempic is only a weekly injection, whereas Victoza must be given daily. Available Strengths and Pen Sizes: • Prefilled pen containing 18 milligrams (mg) in 3 milliliters (mL ...

Novo Nordisk's Victoza (liraglutide) has become the only approved diabetes drug in the GLP-1 agonist class shown to demonstrate a cardiac safety benefit, although it faces competition from a ...

Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 ...

The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ... single-patient-use pen that delivers doses of 0.6mg, 1.2mg, or 1.8mg in ...

The US Food and Drug Administration (FDA) revealed on Monday that it has approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter. Marketed by Denmark’s Novo ...

The FDA has approved the first generic of Victoza (liraglutide injection) for adults and pediatric patients older than 10 with type 2 diabetes, according to a recent news release. This 18 mg/3 mL ...

Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.

To hear Novo tell it, the outsourcing group OFA shouldn’t be allowed to place liraglutide on its compounding list given that FDA-approved generics to Victoza are available. Further, the OFA has ...

In its Citizen Petition to the FDA, Novo Nordisk argued that there is no clinical need to allow compounding for liraglutide, the type 2 diabetes injection it sells as Victoza. Novo Nordisk last month ...